Tegretol XR - (100, 200, 400 mg; Tablet, Extended Release)

Generic Name	Carbamazepine	Innovator	Novartis
Dosage	100, 200, 400 mg; Tablet, Extended Release	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	More Than 5	Tentative Approvals	None
Final Approvals	More Than 5	Generic Launches	More Than 5
Indication	Used to treat seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*** (****)	*** \ ***	*** *********	*** *********	********	******** ** ***** **, ****
***** ******	** \ **	**** ***	**** ***	********	******** ** ***** **, ****

Chronology Of Events